Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000167.xml
Download PDF
Int J Angiol 2020; 29(02): 108-112
DOI: 10.1055/s-0040-1708476
DOI: 10.1055/s-0040-1708476
Invited Articles
Catheter Ablation in the Treatment of Atrial Fibrillation
Further Information
Publication History
Publication Date:
28 April 2020 (online)
Abstract
Catheter ablation (CA) of the pulmonary veins for atrial fibrillation (AF) is growing exponentially and is the most commonly performed electrophysiologic procedure. Initial descriptions focused on CA for paroxysmal AF, and now more recently expanded in application to persistent AF and those with comorbid heart failure. Efforts to improve success have and continue to address issues such as pulmonary vein “reconnection” following ablation through different ablative energy modalities, and the use of a “hybrid” surgical/endocardial combined approach in persistent forms of AF. Technologic advances as well are concurrently seeking to improve safety, particularly regarding the incidence of atrio-esophageal fistula in this seemingly ever-growing ablation population.
-
References
- 1 Calkins H, Reynolds MR, Spector P. , et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2 (04) 349-361
- 2 Al Halabi S, Qintar M, Hussein A. , et al. Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized control trials. JACC Clin Electrophysiol 2015; 1 (03) 200-209
- 3 Haïssaguerre M, Jaïs P, Shah DC. , et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339 (10) 659-666
- 4 Stiles MK, John B, Wong CX. , et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the “second factor”. J Am Coll Cardiol 2009; 53 (14) 1182-1191
- 5 Nattel S. Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms. Can J Cardiol 2013; 29 (10) 1147-1149
- 6 Pappone C, Santinelli V, Manguso F. , et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109 (03) 327-334
- 7 Katritsis DG, Pokushalov E, Romanov A. , et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol 2013; 62 (24) 2318-2325
- 8 Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol 2005; 16 (02) 229-232
- 9 Lee SH, Tai CT, Hsieh MH. , et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation. J Am Coll Cardiol 2005; 46 (06) 1054-1059
- 10 Shah D, Haïssaguerre M, Jais P, Hocini M. Nonpulmonary vein foci: do they exist?. Pacing Clin Electrophysiol 2003; 26 (7 Pt 2): 1631-1635
- 11 Di Biase L, Burkhardt JD, Mohanty P. , et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010; 122 (02) 109-118
- 12 Santangeli P, Zado ES, Hutchinson MD. , et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm 2016; 13 (02) 374-382
- 13 Verma A, Macle L, Cox J, Skanes AC. ; CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter. Can J Cardiol 2011; 27 (01) 60-66
- 14 January CT, Wann LS, Alpert JS. , et al; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130 (23) 2071-2104
- 15 Wilber DJ, Pappone C, Neuzil P. , et al; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303 (04) 333-340
- 16 Stabile G, Bertaglia E, Senatore G. , et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006; 27 (02) 216-221
- 17 Parkash R, Verma A, Tang AS. Persistent atrial fibrillation: current approach and controversies. Curr Opin Cardiol 2010; 25 (01) 1-7
- 18 Brooks AG, Stiles MK, Laborderie J. , et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 2010; 7 (06) 835-846
- 19 Verma A, Jiang CY, Betts TR. , et al; STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015; 372 (19) 1812-1822
- 20 Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011; 121 (08) 2955-2968
- 21 Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 2014; 114 (09) 1483-1499
- 22 Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 2012; 33 (15) 1870-1877
- 23 Corradi D. Atrial fibrillation from the pathologist's perspective. Cardiovasc Pathol 2014; 23 (02) 71-84
- 24 He X, Gao X, Peng L. , et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 2011; 108 (02) 164-175
- 25 Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 2014; 63 (22) 2335-2345
- 26 Kumagai K, Muraoka S, Mitsutake C, Takashima H, Nakashima H. A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18 (10) 1047-1052
- 27 Yamaguchi Y, Kumagai K, Nakashima H, Saku K. Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J 2010; 74 (06) 1096-1103
- 28 Aryana A, Baker JH, Espinosa Ginic MA. , et al. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: a multicenter experience. Heart Rhythm 2018; 15 (08) 1121-1129
- 29 Nademanee K, McKenzie J, Kosar E. , et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43 (11) 2044-2053
- 30 Han FT, Bartus K, Lakkireddy D. , et al. The effects of LAA ligation on LAA electrical activity. Heart Rhythm 2014; 11 (05) 864-870
- 31 Badhwar N, Lakkireddy D, Kawamura M. , et al. Seuential percutaneous LAA ligation and pulmonary vein isolation in patients with persistent AF: initial results of a feasibility study. J Cardiovasc Electrophysiol 2015; 26 (06) 608-614
- 32 Tomassoni G, Duggal S, Muir M. , et al. Long-term follow-up of FIRM-guided ablation of atrial fibrillation: a single-center experience. J Innovations Card Rhythm Management 2015; 6: 2145-2151
- 33 Miller JM, Kalra V, Das MK. , et al. Clinical benefit of ablating localized sources for human atrial fibrillation: The Indiana University FIRM Registry. J Am Coll Cardiol 2017; 69 (10) 1247-1256
- 34 Henley P, Foreman JR, Padanilam BJ. , et al. Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 2019; 30 (04) 493-502
- 35 Haïssaguerre M, Hocini M, Denis A. , et al. Driver domains in persistent atrial fibrillation. Circulation 2014; 130 (07) 530-538
- 36 Pokushalov E, Romanov A, Katritsis DG. , et al. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm 2014; 11 (07) 1131-1138
- 37 Steinberg JS. . Evaluate renal artery denervation in addition to catheter ablation to eliminate atrial fibrillation (ERADICATE-AF) trial. Heart Rhythm Society 40th Annual Scientific late breaking trial session. Available at: https://clinicaltrials.gov/ct2/show/NCT01873352 . Accessed May 9, 2019
- 38 Brachmann J. . Prospective randomized comparison of rotor ablation vs. conventional ablation for the treatment of persistent atrial fibrillation – the REAFFIRM Trial. Heart Rhythm Society 40th Annual late breaking trial session. Available at: https://www.abstractsonline.com/pp8/#!/5753/presentation/31210 . Accessed May 9, 2019
- 39 Reddy V. . Real-time electrogram analysis for drivers of atrial fibrillation (Radar): a multi-center, FDA-IDE, clinical trial of persistent AF. Heart Rhythm Society 40 th Annual late breaking trial session. Available at: https://clinicaltrials.gov/ct2/show/NCT03263702 . Accessed May 10, 2019
- 40 Lee RJ, Lakkireddy D, Mittal S. , et al. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J 2015; 170 (06) 1184-1194
- 41 Neuzil P, Reddy VY, Kautzner J. , et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 2013; 6 (02) 327-333
- 42 Kuck KH, Brugada J, Fürnkranz A. , et al; FIRE AND ICE Investigators. Cryoballoon of radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016; 374 (23) 2235-2245
- 43 Reddy VY, Neuzil P, Koruth JS. , et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019; 74 (03) 315-326
- 44 Ghia KK, Chugh A, Good E. , et al. A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol 2009; 24 (01) 33-36
- 45 Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2009; 2 (04) 362-369
- 46 Guiot A, Savouré A, Godin B, Anselme F. Collateral nervous damages after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol 2012; 23 (04) 346-351
- 47 Lakkireddy D, Reddy YM, Atkins D. , et al. Effect of atrial fibrillation ablation on gastric motility: the atrial fibrillation gut study. Circ Arrhythm Electrophysiol 2015; 8 (03) 531-536
- 48 Knopp H, Halm U, Lamberts R. , et al. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm 2014; 11 (04) 574-578
- 49 Dumonceau JM, Giostra E, Bech C, Spahr L, Schroft A, Shah D. Acute delayed gastric emptying after ablation of atrial fibrillation: treatment with botulinum toxin injection. Endoscopy 2006; 38 (05) 543
- 50 Bunch TJ, Ellenbogen KA, Packer DL, Asirvatham SJ. Vagus nerve injury after posterior atrial radiofrequency ablation. Heart Rhythm 2008; 5 (09) 1327-1330
- 51 Marrouche NF, Brachmann J, Andresen D. , et al; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378 (05) 417-427
- 52 Prabhu S, Taylor AJ, Costello BT. , et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 2017; 70 (16) 1949-1961
- 53 Packer DL, Mark DB, Robb RA. , et al; Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 2019; 321 (13) 1261-1274
- 54 Hesselson AB. . Unpublished data.
- 55 Khoynezhad A, Ellenbogen KA, Al-Atassi T. , et al. Hybrid atrial fibrillation ablation: current status and look ahead. Circ Arrhythm Electrophysiol 2017; 10 (10) e005263
- 56 Zhang J, Sun H, He K, Gu J, Zheng R, Shao Y. Hybrid ablation versus transcatheter ablation for atrial fibrillation: a meta-analysis. Medicine (Baltimore) 2019; 98 (03) e14053
- 57 Beller JP, Downs EA, Ailawadi G. Minimally invasive atrial fibrillation surgery: hybrid approach. Methodist DeBakey Cardiovasc J 2016; 12 (01) 37-40
- 58. De Lurgio D. . CONVERGE – Epi/endo ablation for treatment of persistent atrial fibrillation NCT019843346. Available at: https://clinicaltrials.gov/ct2/show/NCT01984346 . Accessed February 7, 2020
- 59 Pragliola C, Mastroroberto P, Gaudino M, Chello M, Covino E. Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial. Trials 2014; 15: 190